Status:
SUSPENDED
Measles Vaccine in HCW
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Covid19
Eligibility:
All Genders
18-50 years
Phase:
PHASE3
Brief Summary
Till now, mortality reports among children below 9 years remains extremely low despite that the incidence of death toll is high and exceeding 50,000 patients among older population, One speculation fo...
Eligibility Criteria
Inclusion
- Age 18-50 years old
- Subjects who are willing to comply with the requirements of the study protocol and scheduled visits (for example, completion of the subject diary, return for follow-up visits) and who are willing to make themselves available for the duration of the study with access to a consistent means of telephone contact
Exclusion
- acute severe illness
- recent receipt of a blood product
- history of thrombocytopenia
- Pregnant females
- any chronic medical condition
- Any participant receiving any immune suppressive medication
- Immunocompromised staff
- Participants who have egg allergy
- Participants who care for immune compromised hosts
- Participants who test positive for COVID-19 serology prior to randomization
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04357028
Start Date
July 13 2020
End Date
January 1 2021
Last Update
December 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University Hospital
Cairo, Egypt, 11559